| Cash Flow | 2025-05-31 |
|---|---|
| Net loss | 51,395 |
| Depreciation | 3,775 |
| Amortization | 7,251 |
| Impairment expenses | 3,463 |
| Changes in other assets | 50,079 |
| Increase in accounts receivable | -11,500 |
| Increase in interest receivable | -436 |
| Increase in accrued expenses | -1,211 |
| Increase in advances from related parties | -31,058 |
| Net cash provided by (used in) operating activities | -4,528 |
| Net cash provided by (used in) investing activities | 0 |
| Proceeds from sale of common stock | 0 |
| Apic | 3,500 |
| Accrued interest | 0 |
| Net cash provided by financing activities | 3,500 |
| Increase (decrease) in cash and equivalents | -1,028 |
| Cash and cash equivalents at beginning of period | 1,028 |
| Cash and cash equivalents at end of period | 0 |
LAMY (LMMY)
LAMY (LMMY)